Haemorrhage of more than 500 mL |
About 68 women per 1,000 would be expected to have a haemorrhage of more than 500 mL (so 932 per 1,000 would not)
|
About 188 women per 1,000 would be expected to have a haemorrhage of more than 500 mL (so 812 per 1,000 would not)
|
About 120 per 1,000 fewer women would be expected to have a haemorrhage of more than 500 mL with active management, so for 880 there would be no difference
|
Haemorrhage of more than 1 litre |
About 13 women per 1,000 would be expected to have a haemorrhage of more than 1 litre (so 987 per 1,000 would not)
|
About 29 women per 1,000 would be expected to have a haemorrhage of more than 1 litre (so 971 per 1,000 would not)
|
About 16 per 1,000 fewer women would be expected to have a haemorrhage of more than 1 litre with active management, so for 984 there would be no difference
|
Need for blood transfusion |
About 13 women per 1,000 would be expected to need a blood transfusion (so 987 per 1,000 would not)
|
About 35 women per 1,000 would be expected to need a blood transfusion (so 965 per 1,000 would not)
|
About 23 per 1,000 fewer women would be expected to need a blood transfusion with active management, so for 977 there would be no difference
|
Postpartum anaemia (haemoglobin less than 9 g/dL) |
About 30 women per 1,000 would be expected to have anaemia (so 970 per 1,000 would not)
|
About 60 women per 1,000 would be expected to have anaemia (so 940 per 1,000 would not)
|
About 30 per 1,000 fewer women would be expected to have anaemia with active management, so for 970 there would be no difference
|
Need for further uterotonics |
About 47 women per 1,000 would be expected to need further uterotonics (so 953 per 1,000 would not)
|
About 247 women per 1,000 would be expected to need further uterotonics (so 753 per 1,000 would not)
|
About 200 per 1,000 fewer women would be expected to need further uterotonics with active management, so for 800 there would be no difference
|
Side effects (nausea and vomiting, headache, hypertension, readmission for bleeding) |
About 186 women per 1,000 would be expected to have these side effects (so 814 per 1,000 would not)
|
About 90 women per 1,000 would be expected to have these side effects (so 910 per 1,000 would not)
|
About 96 per 1,000 more women would be expected to have these side effects with active management, so for 904 there would be no difference
|